全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Botox: The Deadly Beauty

DOI: 10.4236/fmar.2019.71003, PP. 13-17

Keywords: Botulinum Toxin, Sudden Death, Botox Injection

Full-Text   Cite this paper   Add to My Lib

Abstract:

Botox injection is the best known as a group of medication that uses various forms of Botulinum toxin A to temporarily paralyze muscle. It primarily reduces the appearance of some facial wrinkles and it is known as Botox Cosmetic. It is a popular treatment among people who want to achieve younger look. A 34-year-old female collapsed at beauty salon soon after receiving Botox injection. Although resuscitation was done in the emergency unit, hospital, she could not be revived and succumbed to death. This case report highlights the rare case of sudden death after Botox injection. We would like people to raise the awareness of unexpected occurrence after Botox injection while they make themselves beautify.

References

[1]  Kukreja, R. and Singh, B.R. (2009) Botulinum Neurotoxins: Structure and Mechanism of Action. Microbial Toxins: Current Research and Future Trends. Caister Academic Press.
[2]  Food and Drug Administration. How Drugs Are Developed and Approved.
https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/
[3]  Irvine, CA. (2012) BOTOX Cosmetic Product Information: BOTOX Cosmetic (onabotulinumtoxinA).
http://www.allergan.com/products/medical_aesthetics/botox_cosmetic.htm
[4]  Lorne, K.R., Kristen, A.T. and Grace, S. (2014) The First Case Report of a Systemic Allergy to OnabotulinumtoxinA (Botox) in a Healthy Patient. Aesthetic Surgery Journal, 34, 766-768.
[5]  Li, M., Goldberger, B.A. and Hopkins, C. (2005) Fatal Case of BOTOX-Related Anaphylaxis? Journal of Forensic Sciences, 50, 169-172.
https://doi.org/10.1520/JFS2004196
[6]  Robert, A.H. (2017) FDA Approves Botox to Treat Chronic Migraines: BOTOX (R) Injections in Plastic Surgery WebMD.
[7]  Khoklov, V.D., Krut, M.I. and Shashko, S. (2012) Anaphylactic Shock Following Administration of Lidocaine after Negative Skin Test. Klin Med (Mosk), 90, 62-64. (In Russian)
[8]  Coté, T.R., Mohan, A.K., Polder, J.A., Walton, M.K. and Braun, M.M. (2005) Botulinum Toxin Type A Injections: Adverse Events Reported to the US Food and Drug Administration in Therapeutic and Cosmetic Cases. Journal of the American Academy of Dermatology, 53, 407-415.
https://doi.org/10.1016/j.jaad.2005.06.011
[9]  Daniel, S.C., Esther, T.T. and Susan, E. (2006) Botulism in 4 Adults Following Cosmetic Injections with an Unlicensed, Highly Concentrated Botulinum Preparation. JAMA, 296, 2476-2479.
https://doi.org/10.1001/jama.296.20.2476

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413